Advertisement
U.S. Markets closed

Cann Group Limited (CNGGF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
0.00500.0000 (0.00%)
At close: 04:00PM EDT

Cann Group Limited

262-276 Lorimer Street
Ground Floor
Port Melbourne, VIC 3207
Australia
61 3 9095 7088
https://www.canngrouplimited.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

NameTitlePayExercisedYear Born
Ms. Jennifer Lee Pilcher AGIA, BBS, C.A.CEO, MD & Executive Director412.27kN/AN/A
Mr. David HineHead of FinanceN/AN/AN/A
Mr. Steven Notaro BA, J.D.Head of Legal and Regulatory Affairs & Company Secretary138.47kN/AN/A
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Corporate Governance

Cann Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.